Clinical Study of TQA3605 Tablets Combined With Nucleoside (Acid) Analogs (NAs) Drugs Compared With NAs Drugs in the Treatment of Chronic Hepatitis B Virus (HBV) Infection

Clinical trial NCT06644417 · COMPLETED

Trial details

NCT number: NCT06644417
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

HBV Infection With LLV

Start date: 2024-11-14
Primary completion: 2025-08-25
Enrollment: 122

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.